| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.47 | 0.01 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |